⌕
Staar Surgical · STAA · Nasdaq
Tenet 47 · Mixed
Compare
$26.01−1.44%At closeTenet 47 · Mixed
$26.01−0.38 (−1.44%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

Staar Surgical (STAA) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

● Defense WorldNov 5, 2026 · 01:15 ETEARNINGS EXPECTED BY FEB 22
What STAAR Surgical (STAA) Said on Its Q3 Earnings Call

STAAR Surgical (NASDAQ: STAA) reported lower third-quarter sales and profit on a reported basis, but said revenue rose 21% after excluding a prior-year deferred sales item in China. The implantable lens maker also said d…

● Seeking AlphaNov 5, 2026 · 01:14 ETEARNINGS EXPECTED BY FEB 22
STAAR Surgical Company (STAA) Q3 2026 Earnings Call Transcript

STAAR Surgical Company (STAA) Q3 2026 Earnings Call Transcript…

● Zacks Investment ResearchNov 4, 2026 · 20:46 ETEARNINGS EXPECTED BY FEB 22
Staar Surgical (STAA) Surpasses Q3 Earnings and Revenue Estimates

Staar Surgical (STAA) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.46 per share a year ago.…

● Business WireNov 4, 2026 · 16:01 ETCOMPANY'S OWN WORDSEARNINGS EXPECTED BY FEB 22
STAAR Surgical Reports Third Quarter 2026 Results

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), the global leader in phakic IOLs with the EVO™ family of Implantable Collamer® Lenses (EVO ICL™) for vision correcti…

● Business WireOct 29, 2026 · 07:01 ETCOMPANY'S OWN WORDS
STAAR Surgical Appoints Pascal Aeschlimann as Vice President of Asia Pacific

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correctio…

● Zacks Investment ResearchOct 28, 2026 · 11:07 ETEARNINGS EXPECTED BY FEB 22
Earnings Preview: Staar Surgical (STAA) Q3 Earnings Expected to Decline

Staar Surgical (STAA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.…

● PRNewsWireOct 21, 2026 · 16:18 ET
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of STAAR Surgical Company (NASDAQ: STAA)

NEW YORK, Oct. 21, 2026 /PRNewswire/ -- Levi & Korsinsky announces that it has commenced an investigation of STAAR Surgical Company (NASDAQ: STAA) concerning possible breaches of fiduciary duties. If you are a current sh…

● Defense WorldOct 17, 2026 · 03:23 ETEARNINGS EXPECTED BY FEB 22
B. Riley Wealth Advisors Inc. Makes New $546,000 Investment in STAAR Surgical Company $STAA

B. Riley Wealth Advisors Inc. bought a new stake in STAAR Surgical Company (NASDAQ: STAA) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 2…

● Business WireOct 8, 2026 · 15:14 ETCOMPANY'S OWN WORDS
STAAR Surgical Names Andrew Pilon as Vice President of Business Development

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correctio…

● The Motley FoolSep 29, 2026 · 19:01 ET
Why Staar Surgical Zoomed Almost 8% Higher on Tuesday

That pundit now believes it's a buy. He cited positive sales momentum, especially in a key market overseas.…

● BenzingaSep 29, 2026 · 10:37 ET
This Staar Surgical Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.…

● Defense WorldSep 29, 2026 · 06:15 ETEARNINGS EXPECTED BY FEB 22
Contrasting Sensus Healthcare (NASDAQ:SRTS) and STAAR Surgical (NASDAQ:STAA)

Sensus Healthcare (NASDAQ: SRTS - Get Free Report) and STAAR Surgical (NASDAQ: STAA - Get Free Report) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based o…

● The Motley FoolSep 25, 2026 · 19:21 ET
Why Staar Surgical Stock Soared Today

It anticipates this will run for one year. The company's recent fundamentals have been rather impressive.…

● Business WireSep 24, 2026 · 16:01 ETCOMPANY'S OWN WORDS
STAAR Surgical Board Approves $50 Million Share Repurchase Authorization

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO™ family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that it…

● GuruFocusSep 23, 2026 · 19:45 ET
Is Staar Surgical Co (STAA) a Bargain After 4.1% Drop? GF Value Says Undervalued

On September 23, 2026, Staar Surgical Co (STAA) shares fell by 4.1%, closing at $19.80. The stock has had a turbulent year, trading within a 52-week range of $1…

● PRNewsWireSep 23, 2026 · 18:15 ET
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of STAAR Surgical Company (NASDAQ: STAA).

NEW YORK, Sept. 23, 2026 /PRNewswire/ -- Levi & Korsinsky announces that it has commenced an investigation of STAAR Surgical Company (NASDAQ: STAA) concerning possible breaches of fiduciary duties.…

● Business WireSep 10, 2026 · 07:00 ETCOMPANY'S OWN WORDS
STAAR Surgical Releases Landmark Global Report Showing Structural Multi-Market Shift Toward Lens-Based Vision Correction

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO™ family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today released a new re…

● Business WireSep 8, 2026 · 16:01 ETCOMPANY'S OWN WORDS
STAAR Surgical Names Former CEO David Bailey as Chief Commercial Officer

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correctio…

● Business WireSep 2, 2026 · 16:01 ETCOMPANY'S OWN WORDS
STAAR Surgical Names Medtech Innovator and Platform Builder Ben Park as Chief Technology Officer

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correctio…

● Defense WorldAug 27, 2026 · 03:39 ETEARNINGS EXPECTED BY FEB 22
American Capital Management Inc. Makes New $24.29 Million Investment in STAAR Surgical Company $STAA

American Capital Management Inc. purchased a new stake in STAAR Surgical Company (NASDAQ: STAA) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commissio…

● Zacks Investment ResearchAug 17, 2026 · 10:16 ET
Deciphering Staar Surgical (STAA) International Revenue Trends

Review Staar Surgical's (STAA) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.…

Kept in their own lane. A press release is the company talking, not reporting.

Expected by Feb 22. Report dates come from the data provider's upcoming-earnings feed and are its estimate, not a date the company has set.

Article counts from the last market-wide feed page, across every symbol we track and not just STAA · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.